Tomás Zambrano - Concepedia

Author

Tomás Zambrano

Universidad de La Frontera ORCID

Also Known As

T Zambrano, T. Zambrano, T.D. Barreto Zambrano, Tomas Zambrano, Tomás Zambrano

Publications

742

Citations

H-Index

Concepts

All Affiliations

Universidad de La Frontera Universidade de São Paulo University of Chile

About

Tomás Zambrano is an author at Universidad de La Frontera specializing in medicine, atherosclerosis, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	221
2	Public Health	3	3	104
3	Cell Biology	3	3	69
4	Natural Sciences	1	1	16
5	Biochemistry	1	1	29

Tomás Zambrano

Publications

425

Citations

H-Index

Page 1

	Year	Citations
Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia Alexy Rosales, Marysol Alvear, Alejandro Cuevas, Clinica Chimica Acta Metabolic SyndromeLipid DisorderCardiovascular DiseasePharmacogenetic PredictorsMedicine	2011	49
Bacterial Community Profile of the Gut Microbiota Differs between Hypercholesterolemic Subjects and Controls Camilo Rebolledo, Alejandro Cuevas, Tomás Zambrano, BioMed Research International DysbiosisHost-microbe InteractionsGut MicrobiotaBacterial Community ProfileGut Microbiology	2017	42
Polyphenol-Rich Extract from Propolis Reduces the Expression and Activity of<i>Streptococcus mutans</i>Glucosyltransferases at Subinhibitory Concentrations Jorge Jesús Veloz, Nicolás Saavedra, Marysol Alvear, BioMed Research International	2016	37
Statins differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: A pilot study Tomás Zambrano, Rosário Dominguez Crespo Hirata, Mário Hiroyuki Hirata, European Journal of Pharmaceutical Sciences InflammationHyperlipidemic SubjectsAtherosclerosisMicrornas ExpressionGene Expression	2018	32
Polyphenols from Chilean Propolis and Pinocembrin Reduce MMP-9 Gene Expression and Activity in Activated Macrophages Nicolás Saavedra, Alejandro Cuevas, Marcela Frota Cavalcante, BioMed Research International InflammationChilean PropolisAnti-inflammatoryBiochemistryActivated Macrophages	2016	29
APOE Polymorphisms Contribute to Reduced Atorvastatin Response in Chilean Amerindian Subjects Jenny Lagos, Tomás Zambrano, Alexy Rosales, International Journal of Molecular Sciences	2015	27
SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals Yalena Prado, Nicolás Saavedra, Tomás Zambrano, International Journal of Molecular Sciences	2015	24
<scp>HMGCR</scp> rs17671591 <scp>SNP</scp> Determines Lower Plasma <scp>LDL</scp>‐C after Atorvastatin Therapy in Chilean Individuals Alejandro Cuevas, César Fernández, Luis Ferrada, Basic & Clinical Pharmacology & Toxicology	2015	24
Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study. Tomás Zambrano, Mário Hiroyuki Hirata, Álvaro Cerda, PubMed	2015	24
Altered microRNome Profiling in Statin-Induced HepG2 Cells: A Pilot Study Identifying Potential new Biomarkers Involved in Lipid-Lowering Treatment Tomás Zambrano, Rosário Dominguez Crespo Hirata, Mário Hiroyuki Hirata, Cardiovascular Drugs and Therapy InflammationLipid-lowering TreatmentStatin-induced Hepg2 CellsMedicineLipoprotein Metabolism	2015	21

Page 1